Method of producing a pharmacologically stable form of lyophilised, active preparations of purified bacteriophages
    2.
    发明授权
    Method of producing a pharmacologically stable form of lyophilised, active preparations of purified bacteriophages 有权
    制备纯化噬菌体的冻干活性制剂的药理稳定形式的方法

    公开(公告)号:US09238798B2

    公开(公告)日:2016-01-19

    申请号:US13059815

    申请日:2009-10-29

    IPC分类号: A61K35/13 C12N7/00

    摘要: The subject the present invention is a method of producing a pharmacologically stable form of purified and lyophilised bacteriophage preparations of increased stability and antibacterial activity, characterized in that phages produced from a bacterial lysate, for example by ultrafiltration on ultrafiltration membranes, containing a high molecular weight preparation of purified phages is stabilised most preferably with a probiotic extract in the presence or absence of neutral salts and/or organic solvents, lyophilised, characterised via HPLC chromatography, by SDS-PAGE, and bacterial lysis biological assays, and then stored under a vacuum, where the active lyophilisate is destined for phage therapy of infections and tumors.

    摘要翻译: 本发明的主题是制备具有增加的稳定性和抗菌活性的纯化和冻干的噬菌体制剂的药理稳定形式的方法,其特征在于从细菌裂解物产生的噬菌体,例如通过在超滤膜上超滤,含有高分子量 纯化噬菌体的制备在存在或不存在中性盐和/或有机溶剂的情况下最优选用益生菌提取物稳定,冻干,通过HPLC色谱法,通过SDS-PAGE表征,细菌裂解生物测定法,然后在真空下储存 ,其中活性冻干物用于感染和肿瘤的噬菌体治疗。